ARCHIVES

Competing Strategies For Breast Cancer? Brinker Tries to Ensure acceptance Of Report, Visco Urges Broad Effort

This article is from The Cancer Letter archive.

Vol. 19 No. 39 | October 8, 1993

Download PDF Visit The Full Archive

Related Articles

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Comprehensive Center NCAB Evaluations

June 2, 1978

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

National Action Plan: Steering committee Votes No Confidence In HHS Official.

August 15, 1997

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer

July 16, 1999